Last reviewed · How we verify
A Prospective, Exploratory Study to Evaluate the Efficacy of Peginterferon α-2b Injection Combined With Carbon Dioxide(CO2) Laser in the Treatment of Condylomata Acuminata
This is a prospective, randomized, open-label, controlled study, aiming to enroll 30 patients with Condylomata Acuminata. The study consists of two phases: a treatment phase (Weeks W1-W12) and an observation phase (Weeks W13-W24). Eligible patients will be randomly allocated into three groups at a ratio of 1:1:1: Test Group 1, Test Group 2, or the Control Group. And clinical cure, recurrence rates, adverse events, vital signs, laboratory tests, drug exposure doses, premature withdrawals will be analyzed.
Details
| Lead sponsor | Zhangyu Bu |
|---|---|
| Phase | NA |
| Status | NOT_YET_RECRUITING |
| Enrolment | 30 |
| Start date | 2024-07 |
| Completion | 2025-12 |
Conditions
- Condylomata Acuminata
Interventions
- Peginterferon α-2b injection
- Peginterferon α-2b injection
- CO2 laser
Primary outcomes
- Clinical cure rate — Week 12
Countries
China